SARAH ANDERSON: Open Payments
NPI 1639723893 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 18 payments from 13 companies in 2025. Trend: 2023 $204 · 2024 $2,604 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $191 |
| Janssen Biotech, Inc. | 1 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| PFIZER INC. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| COLOPLAST CORP | 1 | $21 |
| ACCORD HEALTHCARE, INC. | 1 | $19 |
| IMMUNITYBIO, INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: GEMTESA, RYBREVANT, Nubeqa, XTANDI, PLUVICTO, LYNPARZA, SpeediCath, Camcevi.
Industry payments across VA — which companies pay providers there.
